Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.1 (
S1 nuclease
)
3,660
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Eukaryotic initiation factor (eIF) 1A (formerly called
eIF-4C
) is a small protein that promotes dissociation of 80 S ribosomes into subunits, stabilizes methionyl-tRNA binding to 40 S ribosomal subunits, and is required for the binding of mRNA to ribosomes. The sequence of
eIF-1A
derived from its cloned cDNA possesses a high frequency of basic residues and acidic residues at its N and C termini, respectively. Northwestern blotting with a fragment of mRNA indicates that
eIF-1A
binds RNA. Overexpression of the human
eIF-1A
cDNA in Escherichia coli and subsequent purification enabled us to prepare large quantities of active factor. The level of
eIF-1A
in HeLa cells determined by Western immunoblotting is 0.01% of total protein, which corresponds to 0.2 molecules of
eIF-1A
/ribosome. The moderate abundance means that
eIF-1A
is equal to or in excess of native 40 S subunits and suggests that the factor may not be limiting for protein synthesis, a conclusion reinforced by the failure of overproduced
eIF-1A
to stimulate translation rates in transiently transfected COS-1 cells.
S1 nuclease
protection and primer extension analyses show that
eIF-1A
mRNA possesses an unusually long 5'-untranslated leader that is very G/C-rich (72%). Unexpectedly, the mRNA is efficiently translated in HeLa cells as judged by polysome profile analyses.
...
PMID:Protein synthesis initiation factor eIF-1A is a moderately abundant RNA-binding protein. 789 Jul 5